TXT In plain English
Company description
AVENTIS PHARMA LIMITED is a UK company whose Companies House status is “Active” and whose registered company type is “Private Limited Company”. Incorporated on 18 December 1980; registered for 45 years; registered office reported in READING, BERKSHIRE, ENGLAND. Its primary declared activity is 46460 · Wholesale of pharmaceutical goods.
This BritDB profile also contains linked public records: 1 PSC record, 30 trade marks, 14 procurement records. This description is assembled from public data, is not a reliability assessment, and should be checked against the cited sources before a legally significant decision.
Web facts are never added from a name match alone. Internet enrichment requires the exact Companies House ID in Wikidata, and ambiguous results are excluded.
01 Company overview
Identity and registration
- Official name
- AVENTIS PHARMA LIMITED
- Company number
- 01535640
- Company type
- Private Limited Company
- Status
- Active
- Country of origin
- United Kingdom
- Dissolution date
- Not supplied
- Accounts category
- FULL
- Mortgage charges
- 1 total · 1 outstanding · 0 satisfied
- Limited partnership members
- 0 general · 0 limited
A registered office is not necessarily a trading location. The address is reproduced from the Companies House bulk record and should be interpreted in that legal context.
02 Filing dates
Accounts and statements
Last accounts made up to
31 December 2025Next accounts due
30 September 2027Last statement made up to
22 December 2025Next statement due
5 January 2027BritDB does not infer overdue status when the source does not state it.
03 Workforce reporting
Gender pay gap
- Median bonus gap
- 16.5%
- Mean bonus gap
- 33.1%
- Women receiving bonus
- 98.0%
- Men receiving bonus
- 99.0%
- Women in top quartile
- 48.0%
- Women in upper middle quartile
- 56.0%
- Women in lower middle quartile
- 59.0%
- Women in lower quartile
- 73.0%
Earlier reporting years (8)
- 500 to 9997.3% median hourly gap
- 500 to 9998.0% median hourly gap
- 500 to 99911.9% median hourly gap
- 500 to 9999.6% median hourly gap
- 500 to 9998.6% median hourly gap
- 500 to 99910.3% median hourly gap
- 500 to 9999.2% median hourly gap
- 500 to 99912.8% median hourly gap
Positive gaps mean men were paid more; negative gaps mean women were paid more. These figures are employer-reported and describe the workforce distribution, not equal pay for the same job. The company link uses the exact Companies House number supplied by the service.
04 Supplier payments
Payment practices and performance
- Reporting period
- 1 January 2026 – 30 June 2026
- Filed
- 31 July 2026
- Shortest standard term
- 0 days
- Longest standard term
- 90 days
- E-invoicing offered
- Yes
- Supply-chain finance
- Offered
- Payment codes
- No
- Construction retentions
- No qualifying construction contracts
Complete reported payment fields
- Policy regime
- Regime-3
- Financial period started
- 1 January 2026
- Qualifying contracts
- Yes
- Payments made
- Yes
- Invoice value paid within 30 days
- £112,321,610
- Invoice value paid in 31–60 days
- £119,888,461
- Invoice value paid after 60 days
- £1,557,135
- Invoice value paid outside agreed terms
- £98,687,702
- Invoices paid in 31–60 days
- 51.0%
- Invoices unpaid due to dispute
- 1.0%
- Maximum contractual payment period
- 90 days
- Supplier-list charging policy
- No
- Supplier-list charges made
- No
Reported terms and dispute process
- Standard payment terms
Our standard payment terms are 90 days from receipt of a valid invoice. Payment is made within 90 days, provided the invoice is accurate, complies with our invoicing requirements, and has been approved in accordance with our internal processes. Different payment terms may apply where contractually agreed with individual suppliers.
- Other payment-term information
Intercompany invoices and suppliers paid by direct debit have been identified separately from third-party suppliers for reporting purposes. However, they remain included within the overall payment performance figures. Intercompany transactions are primarily with wholly owned group companies and may affect reported payment performance, as priority is given to ensuring that third-party suppliers are paid in accordance with agreed payment terms.
- Dispute resolution process
In the first instance, supplier queries and disputes should be directed to our S2P Contact Centre using the email address or telephone number provided on every Purchase Order. The query will then be forwarded to the relevant requester of the goods or services for review and resolution. Where a resolution cannot be reached, the matter will be escalated to the S2P Business Partner and the responsible Buyer, who manages the supplier relationship, to facilitate timely resolution.
Earlier payment reports (11 shown)
- 51.0 average days to pay43.0% outside terms
- 50.0 average days to pay8.0% outside terms
- 77.0 average days to pay35.0% outside terms
- 75.0 average days to pay35.0% outside terms
- 75.0 average days to pay66.0% outside terms
- 87.0 average days to pay46.0% outside terms
- 69.0 average days to pay40.0% outside terms
- 60.0 average days to pay33.0% outside terms
- 64.0 average days to pay26.0% outside terms
- Average time not suppliedLate-payment rate not supplied
- 52.0 average days to pay29.0% outside terms
This is a company-submitted statutory disclosure, not a credit rating. BritDB preserves the reporting period and links the report only through the Companies House number supplied by the official service. Percentages describe payments made during that period and may change in later reports.
05 Global legal identity
Legal Entity Identifier
AVENTIS PHARMA LIMITED
LEI 549300FHMPUBGQQXOZ27 · jurisdiction GB
- Legal form
- H0PO
- Entity category
- GENERAL
- Entity created
- Not supplied
- Initial LEI registration
- 18 December 2013
- LEI last updated
- 31 July 2023
- Next renewal
- 29 November 2019
- Managing LOU
- 213800WAVVOPS85N2205
- Legal address
- ONE, ONSLOW STREET, GUILDFORD, GB-SRY, GU1 4YS, GB
- Headquarters address
- 1 ONSLOW STREET, GUILDFORD, GB-SRY, GU1 4YS, GB
GLEIF Level 2 relationships
IS DIRECTLY CONSOLIDATED BY
From LEI 549300FHMPUBGQQXOZ27 to LEI 549300H4ZG7JIH8FZJ30
- Related legal entity
- SANOFI-AVENTIS UK HOLDINGS LIMITED →
- Initial registration
- 18 December 2013
- Last updated
- 31 July 2023
- Next renewal
- 29 November 2019
- Validation sources
- FULLY_CORROBORATED
- Validation documents
- ACCOUNTS_FILING
- Relationship periods
- Start: 2017-01-01T00:00:00Z; End: 2017-12-31T00:00:00Z; Type: ACCOUNTING_PERIOD; Start: 2017-12-08T00:00:00Z; Type: RELATIONSHIP_PERIOD; Type: DOCUMENT_FILING_PERIOD
- Qualifiers
- Dimension: ACCOUNTING_STANDARD; Category: OTHER_ACCOUNTING_STANDARD
- Validation reference
- https://beta.companieshouse.gov.uk/company/01535640/filing-history/MzIyNjkyMDcwNmFkaXF6a2N4/document?format=pdf&download=0
IS ULTIMATELY CONSOLIDATED BY
From LEI 549300FHMPUBGQQXOZ27 to LEI 549300E9PC51EN656011
- Initial registration
- 18 December 2013
- Last updated
- 31 July 2023
- Next renewal
- 29 November 2019
- Validation sources
- FULLY_CORROBORATED
- Validation documents
- ACCOUNTS_FILING
- Relationship periods
- Start: 2017-01-01T00:00:00Z; End: 2017-12-31T00:00:00Z; Type: ACCOUNTING_PERIOD; Start: 2017-12-08T00:00:00Z; Type: RELATIONSHIP_PERIOD; Type: DOCUMENT_FILING_PERIOD
- Qualifiers
- Dimension: ACCOUNTING_STANDARD; Category: OTHER_ACCOUNTING_STANDARD
- Validation reference
- https://beta.companieshouse.gov.uk/company/01535640/filing-history/MzIyNjkyMDcwNmFkaXF6a2N4/document?format=pdf&download=0
LEI data provides global legal identity and source-reported relationships, not a credit or regulatory approval. BritDB links Level 1 identities only through GLEIF’s Companies House registration-authority identifier and exact company number; Level 2 parent and fund relationships and reporting exceptions are reproduced as supplied by GLEIF.
06 Supply-chain transparency
Modern slavery statement
- Organisation
- AVENTIS PHARMA LIMITED
- Group submission
- No
- Statement period
- 1 January 2025 – 31 December 2025
- Approved
- 18 June 2026
- Sectors
- Healthcare and pharmaceuticals
Organisation structure
Covered in the statement
Policies
Covered in the statement
Risk assessment
Covered in the statement
Due diligence
Covered in the statement
Training
Covered in the statement
Goals and KPIs
Covered in the statement
Full statement information supplied to the registry
- Reported turnover band
- £100 million to £500 million
- Years producing statements
- More than 5 years
- ILO indicators included
- Not answered
- Registry record updated
- 30 June 2026
A registry entry records what the organisation declared in its statement. It is not an independent audit. Group statements can cover several companies; BritDB preserves each exact source-supplied company-number link and excludes approver names and email addresses.
07 Data protection
ICO fee-payer registration
Aventis Pharma Limited
Registration ZA096038
- Registered from
- 28 January 2015
- Current end date
- 27 January 2027
This is a candidate association, not an official Companies House link. The ICO file supplies no company number. The organisation name and postcode uniquely matched this company in the current snapshot. BritDB excludes all DPO contact fields and does not publish unmatched personal entries.
08 Public procurement
Contracts Finder awards
Advance Purchase Agreement
Business Energy and Industrial Strategy · ocds-b5fd17-bce5d4e8-1b71-447d-8732-7136ca1b157e
- Supplier named in award
- Aventis Pharma Ltd
- Award value
- £1
- Contract period
- 20 September 2021 – 31 December 2022
- Published
- 20 October 2021
- Procedure
- Single tender action (below threshold)
- Main CPV
- 33651600
- Source release ID
- ocds-b5fd17-bce5d4e8-1b71-447d-8732-7136ca1b157e-2021-10-20T16:34:53+01:00
NHS Framework for the Midlands and East, Branded Medicines - Tranche B
NHS England · ocds-b5fd17-a3813112-7a5b-461b-9e42-ccdb117c93ef
- Supplier named in award
- AVENTIS PHARMA LIMITED
- Award value
- £228,156,862
- Contract period
- 1 March 2021 – 28 February 2023
- Published
- 30 April 2021
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-a3813112-7a5b-461b-9e42-ccdb117c93ef-2021-04-30T13:00:26+01:00
Supportive Medicines - additional products (ITU, Antibiotics & EOI medicines)
Department of Health and Social Care (DHSC) · ocds-b5fd17-d83c0d3f-efcc-4d08-aa7c-b86364abc312
- Supplier named in award
- Aventis Pharma ltd t/a Sanofi
- Award value
- £16,295,088
- Contract period
- 1 December 2020 – 1 December 2020
- Published
- 30 April 2021
- Procedure
- Accelerated Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-d83c0d3f-efcc-4d08-aa7c-b86364abc312-2021-04-30T13:17:06+01:00
NHS National Branded Proprietary Products (Interim Agreement) - Contracts Finder Award
NHS England · ocds-b5fd17-3ccdc557-66d1-4229-944d-ab7a9fa89b64
- Supplier named in award
- AVENTIS PHARMA LIMITED
- Award value
- £54,500,000
- Contract period
- 1 May 2020 – 30 April 2021
- Published
- 29 May 2020
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-3ccdc557-66d1-4229-944d-ab7a9fa89b64-2020-05-29T15:39:22+01:00
NHS Framework Agreement for Branded medicines - London - Tranche B - Contracts Finder Opportunity
NHS England · ocds-b5fd17-aaa2bd9e-0fdb-4884-8fca-b0d29a6ed15a
- Supplier named in award
- Aventis Pharma Ltd trading as Sanofi
- Award value
- £251,930,337
- Contract period
- 1 September 2019 – 31 August 2020
- Published
- 1 October 2019
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-aaa2bd9e-0fdb-4884-8fca-b0d29a6ed15a-2019-10-01T15:57:02+01:00
NHS Framework Agreement for Branded Medicines - National
NHS England · ocds-b5fd17-67d93048-4af9-4a0e-b313-bc852f01fca7
- Supplier named in award
- Aventis Pharma Ltd trading as Sanofi
- Award value
- £1,351,341,890
- Contract period
- 1 May 2019 – 30 April 2021
- Published
- 9 August 2019
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-67d93048-4af9-4a0e-b313-bc852f01fca7-2019-08-09T15:57:38+01:00
NHS England - Midlands and East Branded Medicines - Tranche B
NHS England · ocds-b5fd17-6c7a4e2c-58d3-4c41-8f77-dc419f83871c
- Supplier named in award
- Aventis Pharma Ltd Tranding as Sanofi
- Award value
- £295,035,882
- Contract period
- 1 March 2019 – 28 March 2021
- Published
- 9 April 2019
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-6c7a4e2c-58d3-4c41-8f77-dc419f83871c-2019-04-09T11:25:43+01:00
NHS England - Midlands and East Branded Medicines - Tranche B
NHS England · ocds-b5fd17-9878d09a-d11a-4940-a851-2b2b759217f2
- Supplier named in award
- Aventis Pharma Ltd Tranding as Sanofi
- Award value
- £295,035,882
- Contract period
- 1 March 2019 – 28 March 2021
- Published
- 9 April 2019
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-9878d09a-d11a-4940-a851-2b2b759217f2-2019-04-09T11:04:50+01:00
NHS England - Midlands and East Branded Medicines - Tranche B
NHS England · ocds-b5fd17-679e36df-b147-44d9-b0c1-53e4b91250c8
- Supplier named in award
- Aventis Pharma Ltd Tranding as Sanofi
- Award value
- £295,035,882
- Contract period
- 1 March 2019 – 28 March 2021
- Published
- 9 April 2019
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-679e36df-b147-44d9-b0c1-53e4b91250c8-2019-04-09T10:58:14+01:00
NHS England - Midlands and East Branded Medicines - Tranche B
NHS England · ocds-b5fd17-8aaddf75-dd22-4754-b241-885b44819814
- Supplier named in award
- Aventis Pharma Ltd Tranding as Sanofi
- Award value
- £295,035,882
- Contract period
- 1 March 2019 – 28 March 2021
- Published
- 21 March 2019
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-8aaddf75-dd22-4754-b241-885b44819814-2019-03-21T11:50:47Z
NHS England Framework Agreement: South of England (Tranche B)
NHS England · ocds-b5fd17-3dac71e6-cde5-406b-abc4-e91389859bf5
- Supplier named in award
- Aventis Pharma Ltd trading as Sanofi
- Award value
- £501,400,000
- Contract period
- 1 September 2018 – 31 August 2020
- Published
- 1 October 2018
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-3dac71e6-cde5-406b-abc4-e91389859bf5-2018-10-01T08:55:31+01:00
NHS Framework Agreement for Seasonal Influenza Vaccines - National
NHS England · ocds-b5fd17-ba492f63-f2bc-4a12-be58-6d0f310147b4
- Supplier named in award
- Aventis Pharma Ltd
- Award value
- £9,600,000
- Contract period
- 1 December 2018 – 30 November 2019
- Published
- 1 October 2018
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33600000
- Source release ID
- ocds-b5fd17-ba492f63-f2bc-4a12-be58-6d0f310147b4-2018-10-01T11:24:03+01:00
Inactivated flu vaccine 2018 season
DEPARTMENT OF HEALTH · ocds-b5fd17-80bb6e51-adc8-11e6-9901-0019b9f3037b
- Supplier named in award
- AVENTIS PHARMA LIMITED
- Award value
- £0
- Contract period
- 1 August 2018 – 31 July 2021
- Published
- 6 February 2020
- Procedure
- Open procedure (above threshold)
- Main CPV
- 33651000
- Source release ID
- ocds-b5fd17-80bb6e51-adc8-11e6-9901-0019b9f3037b-2020-02-06T11:21:14Z
The supplier link is exact, but the award remains buyer-published procurement data. BritDB requires the GB-COH identifier supplied in the Contracts Finder OCDS release and does not infer suppliers from similar names.
TM UK trade marks
Exact owner-name matches
U K C C UK Cancer Convention
Owner Aventis Pharma Limited · classes 41
- Filed / designated
- 16 June 2010
- Valid until / renewal due
- 16 June 2020
P
Owner Aventis Pharma Limited · classes 5,41
- Filed / designated
- 19 March 2010
- Valid until / renewal due
- 19 March 2020
BOWEL BAROMETER
Owner Aventis Pharma Limited · classes 5,16,41
- Filed / designated
- 6 November 2007
- Valid until / renewal due
- 6 November 2027
Figurative mark
Owner Aventis Pharma Limited · classes 5,41
- Filed / designated
- 7 September 2007
- Valid until / renewal due
- 7 September 2027
Figurative mark
Owner Aventis Pharma Limited · classes 5,41
- Filed / designated
- 7 September 2007
- Valid until / renewal due
- 7 September 2027
Figurative mark
Owner Aventis Pharma Limited · classes 5,16,41
- Filed / designated
- 27 July 2006
- Valid until / renewal due
- 27 July 2026
MIGRON
Owner Aventis Pharma Limited · classes 5
- Filed / designated
- 12 October 1987
- Valid until / renewal due
- 12 October 2018
DRIFTAWAY
Owner Aventis Pharma Limited · classes 5
- Filed / designated
- 20 August 1986
- Valid until / renewal due
- 20 August 2027
MEROTHOL
Owner Aventis Pharma Limited · classes 5
- Filed / designated
- 6 November 1984
- Valid until / renewal due
- 6 November 2025
MEROCAINE
Owner Aventis Pharma Limited · classes 5
- Filed / designated
- 11 March 1978
- Valid until / renewal due
- 11 March 2019
SYNDOL
Owner Aventis Pharma Limited · classes 5
- Filed / designated
- 2 January 1970
- Valid until / renewal due
- 2 January 2025
KOLANTICON
Owner Aventis Pharma Limited · classes 5
- Filed / designated
- 14 May 1969
- Valid until / renewal due
- 14 May 2024
MERACAINE
Owner Aventis Pharma Limited · classes 5
- Filed / designated
- 23 February 1965
- Valid until / renewal due
- 23 February 2020
CLOMID
Owner Aventis Pharma Limited · classes 5
- Filed / designated
- 28 September 1964
- Valid until / renewal due
- 28 September 2019
MEROCET
Owner Aventis Pharma Limited · classes 5
- Filed / designated
- 21 July 1959
- Valid until / renewal due
- 21 July 2018
SELDANE
Owner Aventis Pharma Limited · classes 5
- Filed / designated
- 21 March 1989
- Valid until / renewal due
- 21 March 2006
TRILUFED
Owner Aventis Pharma Limited · classes 5
- Filed / designated
- 7 September 1988
- Valid until / renewal due
- 7 September 2005
TELDANEX
Owner Aventis Pharma Limited · classes 5
- Filed / designated
- 14 June 1988
- Valid until / renewal due
- 14 June 2005
MERONAZE
Owner Aventis Pharma Limited · classes 5
- Filed / designated
- 2 November 1981
- Valid until / renewal due
- 2 November 2002
RELAGESIC
Owner Aventis Pharma Limited · classes 5
- Filed / designated
- 2 February 1979
- Valid until / renewal due
- 2 February 2000
MERLON
Owner Aventis Pharma Limited · classes 5
- Filed / designated
- 21 July 1978
- Valid until / renewal due
- 21 July 1999
MEROL
Owner Aventis Pharma Limited · classes 5
- Filed / designated
- 21 July 1978
- Valid until / renewal due
- 21 July 1999
MERALEN
Owner Aventis Pharma Limited · classes 5
- Filed / designated
- 21 July 1978
- Valid until / renewal due
- 21 July 1999
MERALON
Owner Aventis Pharma Limited · classes 5
- Filed / designated
- 21 July 1978
- Valid until / renewal due
- 21 July 1999
MERASAN
Owner Aventis Pharma Limited · classes 5
- Filed / designated
- 28 April 1978
- Valid until / renewal due
- 28 April 1999
RELAGESIC
Owner Aventis Pharma Limited · classes 5
- Filed / designated
- 14 April 1978
- Valid until / renewal due
- 14 April 1999
SYNDETTE
Owner Aventis Pharma Limited · classes 5
- Filed / designated
- 30 September 1977
- Valid until / renewal due
- 30 September 1998
CEPACOL
Owner Aventis Pharma Limited · classes 5
- Filed / designated
- 1 July 1977
- Valid until / renewal due
- 1 July 2008
TRILUDAN
Owner Aventis Pharma Limited · classes 5
- Filed / designated
- 13 August 1976
- Valid until / renewal due
- 13 August 1997
PEXIMER
Owner Aventis Pharma Limited · classes 5
- Filed / designated
- 16 January 1976
- Valid until / renewal due
- 16 January 1997
This is an exact normalised company-name match, not a registrar-confirmed ownership link. Another legal entity can have the same or a very similar name. UKIPO data is a historical 2018 snapshot; verify the owner and current status before relying on it.
09 Ownership and control
People with significant control
Sanofi-Aventis Uk Holdings Limited
- Owns 75% or more of shares
- Controls 75% or more of voting rights
- Can appoint or remove directors
- Country registered
- England
- Legal authority
- Companies Act 2006
- Legal form
- Private Limited Company
- Place registered
- Companies House
- Registration number
- 03203829
- Notified
- 6 April 2016
PSC records are company-filed public-register information. When the exact same displayed individual name occurs at multiple companies, BritDB offers a non-indexed cross-reference page. It is a name match only, not proof that the records describe the same person. Service addresses and partial dates of birth are deliberately omitted.
10 Charity register
Charity Commission links
No exact company-number link in this snapshot
The Charity Commission extract did not explicitly associate this Companies House number with a charity. BritDB does not use a name-only match to fill the gap.
This company-level check covers the Charity Commission for England and Wales. Links are accepted only when the official extract supplies this exact company registration number. Scottish charities now have separate OSCR profiles, but OSCR’s bulk fields do not provide a Companies House number, so BritDB does not infer a company link.
11 Northern Ireland charity register
CCNI exact company links
No unambiguous company-number link found
The CCNI source number did not resolve uniquely to this Companies House record. BritDB did not use a name or address match.
CCNI publishes company numbers without a jurisdiction prefix. BritDB links only when the plausible padded UK and NI candidates resolve to exactly one Companies House company.
12 Sanctions screening
UK Sanctions List
No exact business-registration-number link found
The imported UK Sanctions List did not supply this Companies House number as a UK-linked business identifier. BritDB did not attempt a name-only match.
No exact link is not sanctions clearance. UK restrictions can apply through ownership or control even where an entity is not separately named. Always use the current official list and obtain appropriate advice for a legally significant decision.
13 Public procurement
Find a Tender links
These links use only the GB-COH identifier supplied in the procurement record. A company may have other public-sector work that is absent, older, below publication thresholds or published without a Companies House identifier.
14 Environmental register
Environment Agency waste registrations
No exact company-number registration linked
The licensed Environment Agency subset did not contain this exact Companies House number. BritDB did not attempt a name-only match.
This is a privacy-reduced, exact-company subset. The full official register also includes sole traders and applicants without a matching Companies House number. Check the current Environment Agency register before relying on registration status.
15 Nature of business
Standard Industrial Classification
16 Connected public record
Checks beyond the company register
Charity Commission
0 exact company-number links.
Northern Ireland charities
0 unambiguous company-number links.
Public contracts
1 procurement process linked by exact GB-COH identifier.
Waste register
0 exact company-number registrations.
Corporate notices
The Gazette is not yet connected.
UK Sanctions List
No exact business-registration-number link in this report.
A checked source with no exact link is not a clean bill of health. Unchecked sources remain unknown, while sanctions may also apply through ownership or control of a listed person or entity.
17 Record timeline
Dates in the bulk record
- Detected change
Accounts due date: 2026-09-30 → 2027-09-30
- Accounts
Latest accounts made up to this date
- Confirmation statement
Latest confirmation statement made up to this date
- Incorporation
Company incorporated
18 Provenance
Sources for this profile
Identity, address, status, dates, SIC, previous names and mortgage totals.
Annual employer reports linked by the exact source-supplied Companies House number.
Statutory supplier-payment reports linked by the exact source-supplied Companies House number.
Global legal identities linked through Companies House registration authority RA000585.
Annual statement summaries linked by exact source company number.
Privacy-reduced candidate associations based on a unique exact name-and-postcode match.
Historic awards linked by exact source-supplied GB-COH company identifier.
Current and ceased significant-control records joined by exact company number.
Daily England and Wales extract matched only by the official company registration number.
Daily CCNI export with company links only where the source number resolves unambiguously.
Complete FCDO list checked by exact UK-linked business registration number.
Procurement parties checked only through exact GB-COH identifiers.
Licensed subset linked only by exact Companies House number.
Financial regulation and licences.
Companies House, Charity Commission, OSCR and UK Sanctions List information is public-register data. BritDB reproduces and organises it with source-specific limits; official external links are kept on the dedicated source pages.